Ocean Biomedical Stock Buy Hold or Sell Recommendation
| OCEAW Stock | 0.04 0 9.77% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Ocean Biomedical is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Ocean Biomedical given historical horizon and risk tolerance towards Ocean Biomedical. When Macroaxis issues a 'buy' or 'sell' recommendation for Ocean Biomedical, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Ocean Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Ocean Stock please use our How to Invest in Ocean Biomedical guide. Note, we conduct extensive research on individual companies such as Ocean and provide practical buy, sell, or hold advice based on investors' constraints. Ocean Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Ocean |
Execute Ocean Biomedical Buy or Sell Advice
The Ocean recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ocean Biomedical. Macroaxis does not own or have any residual interests in Ocean Biomedical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ocean Biomedical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Ocean Biomedical Trading Alerts and Improvement Suggestions
| Ocean Biomedical is way too risky over 90 days horizon | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Ocean Biomedical appears to be risky and price may revert if volatility continues | |
| Ocean Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (114.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations | |
| Latest headline from news.google.com: Ocean Biomedical Faces Nasdaq Delisting Threat - TipRanks |
Ocean Biomedical current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ocean analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ocean analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Ocean Biomedical Returns Distribution Density
The distribution of Ocean Biomedical's historical returns is an attempt to chart the uncertainty of Ocean Biomedical's future price movements. The chart of the probability distribution of Ocean Biomedical daily returns describes the distribution of returns around its average expected value. We use Ocean Biomedical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ocean Biomedical returns is essential to provide solid investment advice for Ocean Biomedical.
| Mean Return | 2.18 | Value At Risk | -23.47 | Potential Upside | 29.32 | Standard Deviation | 26.79 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ocean Biomedical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ocean Biomedical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ocean Biomedical or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ocean Biomedical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ocean stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 2.34 | |
β | Beta against Dow Jones | -1.37 | |
σ | Overall volatility | 15.05 | |
Ir | Information ratio | 0.08 |
Ocean Biomedical Volatility Alert
Ocean Biomedical is showing large volatility of returns over the selected time horizon. Ocean Biomedical is a penny stock. Although Ocean Biomedical may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Ocean Biomedical. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Ocean instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Ocean Biomedical Fundamentals Vs Peers
Comparing Ocean Biomedical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ocean Biomedical's direct or indirect competition across all of the common fundamentals between Ocean Biomedical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ocean Biomedical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ocean Biomedical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ocean Biomedical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ocean Biomedical to competition |
| Fundamentals | Ocean Biomedical | Peer Average |
| Number Of Shares Shorted | 27.57 K | 4.71 M |
| EBITDA | (957.74 K) | 3.9 B |
| Net Income | (114.47 M) | 570.98 M |
| Total Debt | 12.12 M | 5.32 B |
| Cash Flow From Operations | (9.43 M) | 971.22 M |
| Number Of Employees | 9 | 18.84 K |
| Total Asset | 5.5 M | 29.47 B |
| Retained Earnings | (196.06 M) | 9.33 B |
| Working Capital | (27.9 M) | 1.48 B |
| Net Asset | 5.5 M |
Ocean Biomedical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ocean . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ocean Biomedical Buy or Sell Advice
When is the right time to buy or sell Ocean Biomedical? Buying financial instruments such as Ocean Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ocean Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electronics Thematic Idea Now
Electronics
Companies manufacturing electronic appliances and goods. The Electronics theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronics Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Ocean Stock Analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.